paper,section,normalized_section
Samaras_2015,Abstract,abstract
Samaras_2015,RESEARCH DESIGN AND METHODS,methods
Samaras_2015,Glucose Status Classification,methods
Samaras_2015,Procedures and Laboratory Analyses,methods
Samaras_2015,Statistical Analyses,methods
Samaras_2015,Cross-Sectional Statistical Analyses,methods
Samaras_2015,Prospective Statistical Analyses,methods
Samaras_2015,RESULTS,results
Samaras_2015,Baseline Disease Prevalence and Metabolic and Inflammatory Associations in IFG,results
Samaras_2015,Two-Year All-Cause Mortality and IFG,results
Samaras_2015,Two-Year Incident Cardiovascular Disease and Stroke and IFG,results
Samaras_2015,Two-Year Incident Cancer and IFG,results
Samaras_2015,"Diabetes Mellitus, Mortality, and Incident Disease",results
Samaras_2015,DISCUSSION,discussion
Samaras_2015,all_tables,tables
Samaras_2015,all_figure_descriptions,figures
Magliano_2010,Abstract,abstract
Magliano_2010,S,intro
Magliano_2010,Risk factors at baseline,methods
Magliano_2010,Causes of death,methods
Magliano_2010,Statistical analyses,methods
Magliano_2010,RESULTS,results
Magliano_2010,"-Adjusted all-cause (A) and CVD (B) mortality HRs (95% CIs) for IFG, IGT, NDM, and KDM compared with NGT according to ethnic",results
Magliano_2010,all_tables,tables
Magliano_2010,all_figure_descriptions,figures
Wang_2008,Abstract,abstract
Wang_2008,Subjects and Methods,methods
Wang_2008,Baseline Study,methods
Wang_2008,Diagnosis of Incident Stroke,methods
Wang_2008,Definitions of the MetS,methods
Wang_2008,Statistical Analyses,methods
Wang_2008,Results,results
Wang_2008,Discussion,discussion
Wang_2008,Wang et al Metabolic Syndrome and Stroke,discussion
Wang_2008,Sources of Funding,misc.
Wang_2008,all_tables,tables
Wang_2008,all_figure_descriptions,figures
Madssen_2012,Abstract,abstract
Madssen_2012,Introduction,intro
Madssen_2012,Material and methods,methods
Madssen_2012,The HUNT study,methods
Madssen_2012,Study variables,methods
Madssen_2012,Study population,methods
Madssen_2012,Follow-up,methods
Madssen_2012,Statistical analysis,methods
Madssen_2012,Results,results
Madssen_2012,Discussion,discussion
Madssen_2012,Potentially confounding factors,discussion
Madssen_2012,Abnormal glucose regulation and fatal CAD,discussion
Madssen_2012,Gender differences,discussion
Madssen_2012,Limitations of the study,discussion
Madssen_2012,Conclusions,conclusions
Madssen_2012,all_tables,tables
Madssen_2012,all_figure_descriptions,figures
Deedwania_2013,Abstract,abstract
Deedwania_2013,Introduction,intro
Deedwania_2013,Methods,methods
Deedwania_2013,Study design and participants,methods
Deedwania_2013,Prediabetes and other baseline measurements,methods
Deedwania_2013,Outcome measures,methods
Deedwania_2013,Assembly of a balanced study cohort,methods
Deedwania_2013,Statistical analysis,methods
Deedwania_2013,Results,results
Deedwania_2013,Baseline characteristics,results
Deedwania_2013,Association of prediabetes with incident heart failure,results
Deedwania_2013,CHS (N=5888),results
Deedwania_2013,Association of prediabetes with other incident cardiovascular events,results
Deedwania_2013,Association of prediabetes with mortality,results
Deedwania_2013,Association of prediabetes with incident diabetes,results
Deedwania_2013,Association of incident diabetes with outcomes,results
Deedwania_2013,Discussion,discussion
Deedwania_2013,Brief summary of the key findings,discussion
Deedwania_2013,Potential explanations for the key,discussion
Deedwania_2013,Age,discussion
Deedwania_2013,Comparison with relevant published findings,discussion
Deedwania_2013,Potential clinical and/or public health implications,discussion
Deedwania_2013,Limitations,discussion
Deedwania_2013,Conclusions,conclusions
Deedwania_2013,all_tables,tables
Deedwania_2013,all_figure_descriptions,figures
Smith_2002,Abstract,abstract
Smith_2002,I,intro
Smith_2002,RESULTS,results
Smith_2002,ORIGINAL INVESTIGATION,results
Smith_2002,INDEPENDENT CONTRIBUTIONS OF FASTING AND 2-HOUR GLUCOSE LEVELS,results
Smith_2002,SUBJECTS AND METHODS,methods
Smith_2002,SETTING AND DESIGN,methods
Smith_2002,SUBJECTS,methods
Smith_2002,MEASURES,methods
Smith_2002,JOINT CONTRIBUTIONS OF FASTING AND 2-HOUR GLUCOSE LEVELS,methods
Smith_2002,ANALYSIS,methods
Smith_2002,ANALYSES STRATIFIED BY FASTING GLUCOSE LEVEL,results
Smith_2002,COMMENT,discussion
Smith_2002,CONCLUSIONS,conclusions
Smith_2002,all_tables,tables
Smith_2002,all_figure_descriptions,figures
Nilsson_2007,Abstract,abstract
Nilsson_2007,Introduction,intro
Nilsson_2007,Subjects and methods,methods
Nilsson_2007,Study design,methods
Nilsson_2007,Lifestyle habits,methods
Nilsson_2007,Physical examination,methods
Nilsson_2007,Laboratory analyses,methods
Nilsson_2007,Definitions of the metabolic syndrome,methods
Nilsson_2007,"Follow-up, definition of end points",methods
Nilsson_2007,Statistical methods,methods
Nilsson_2007,Results,results
Nilsson_2007,Baseline findings,results
Nilsson_2007,Risk of cardiovascular disease according to MetS,results
Nilsson_2007,Modification of waist circumference criteria in IDF definition,results
Nilsson_2007,Prediction by the components of the syndrome,results
Nilsson_2007,Discussion,discussion
Nilsson_2007,Limitations of the study,discussion
Nilsson_2007,all_tables,tables
Nilsson_2007,all_figure_descriptions,figures
Sui_2011,Abstract,abstract
Sui_2011,PATIENTS AND METHODS,methods
Sui_2011,A Prospective Study of Fasting Plasma Glucose and Risk of Stroke in Asymptomatic Men,abstract
Sui_2011,PATIENTS AND METHODS:,abstract
Sui_2011,Mayo Clin,methods
Sui_2011,CliniCal Examination,methods
Sui_2011,StrokE outComES aSCErtainmEnt,methods
Sui_2011,StatiStiCal analySES,methods
Sui_2011,RESULTS,results
Sui_2011,DISCUSSION,discussion
Sui_2011,Fatal stroke Nonfatal stroke Total stroke,discussion
Sui_2011,CONCLUSION,conclusions
Sui_2011,all_tables,tables
Sui_2011,all_figure_descriptions,figures
Wen_2005,Abstract,abstract
Wen_2005,P,intro
Wen_2005,RESEARCH DESIGN AND,methods
Wen_2005,Blood analysis,methods
Wen_2005,Outcome follow-up,methods
Wen_2005,Statistical analysis,methods
Wen_2005,all_tables,tables
Wen_2005,all_figure_descriptions,figures
Mongraw-Chaffin_2017,Abstract,abstract
Mongraw-Chaffin_2017,Introduction,intro
Mongraw-Chaffin_2017,Methods,methods
Mongraw-Chaffin_2017,Study Population,methods
Mongraw-Chaffin_2017,Study Measures,methods
Mongraw-Chaffin_2017,Statistical Analysis,methods
Mongraw-Chaffin_2017,Results,results
Mongraw-Chaffin_2017,Discussion,discussion
Mongraw-Chaffin_2017,all_tables,tables
Mongraw-Chaffin_2017,all_figure_descriptions,figures
Hadaegh_2015,Abstract,abstract
Hadaegh_2015,Introduction,intro
Hadaegh_2015,Methods,methods
Hadaegh_2015,Study population,methods
Hadaegh_2015,"Clinical, anthropometric, and laboratory measurements",methods
Hadaegh_2015,Definition of terms,methods
Hadaegh_2015,Definition of outcome,methods
Hadaegh_2015,Statistics,methods
Hadaegh_2015,Results,results
Hadaegh_2015,Discussion,discussion
Hadaegh_2015,Study strengths and limitations,discussion
Hadaegh_2015,Conclusion,conclusions
Hadaegh_2015,all_tables,tables
Hadaegh_2015,all_figure_descriptions,figures
Wannamethee_2008,Abstract,abstract
Wannamethee_2008,Introduction,intro
Wannamethee_2008,The British Regional Heart Study,methods
Wannamethee_2008,metabolic syndrome and risk of CVD and diabetes,results
Wannamethee_2008,S26,results
Wannamethee_2008,Comparisons between the Framingham Risk Score and the metabolic syndrome,discussion
Wannamethee_2008,Caveats,discussion
Wannamethee_2008,all_tables,tables
Wannamethee_2008,all_figure_descriptions,figures
Barr_2007,Abstract,abstract
Barr_2007,Statistical Analysis,methods
Barr_2007,Results,results
Barr_2007,Baseline Characteristics According to Categories of Abnormal Glucose Metabolism,results
Barr_2007,All-Cause and CVD Mortality,results
Barr_2007,Mortality,results
Barr_2007,Discussion,discussion
Barr_2007,all_tables,tables
Barr_2007,all_figure_descriptions,figures
Jiang_2020,Abstract,abstract
Jiang_2020,Methods,methods
Jiang_2020,Study subjects,methods
Jiang_2020,Glycemic measures,methods
Jiang_2020,Mortality,methods
Jiang_2020,Statistical analysis,methods
Jiang_2020,Results,results
Jiang_2020,Discussion,discussion
Jiang_2020,all_tables,tables
Jiang_2020,all_figure_descriptions,figures
Paprott_2015,Abstract,abstract
Paprott_2015,RESEARCH DESIGN AND METHODS,methods
Paprott_2015,Assessment of Glycemic Status,methods
Paprott_2015,Assessment of Covariates,methods
Paprott_2015,Statistical Analysis,methods
Paprott_2015,RESULTS,results
Paprott_2015,CONCLUSIONS,discussion
Paprott_2015,all_tables,tables
Paprott_2015,all_figure_descriptions,figures
Doi_2010,Abstract,abstract
Doi_2010,Materials and Methods,methods
Doi_2010,Study Population,methods
Doi_2010,Follow-Up Survey,methods
Doi_2010,Definition of Cardiovascular Events,methods
Doi_2010,Risk Factors,methods
Doi_2010,Statistical Analysis,methods
Doi_2010,Ethical Considerations,methods
Doi_2010,Results,results
Doi_2010,Doi et al,results
Doi_2010,Discussion,discussion
Doi_2010,Doi et al Glucose Tolerance Levels and Cardiovascular Disease,discussion
Doi_2010,all_tables,tables
Doi_2010,all_figure_descriptions,figures
Kaarisalo_2006,Abstract,abstract
Kaarisalo_2006,Introduction,intro
Kaarisalo_2006,Study population and methods,methods
Kaarisalo_2006,Study population,methods
Kaarisalo_2006,Methods,methods
Kaarisalo_2006,Statistical analysis,methods
Kaarisalo_2006,Results,results
Kaarisalo_2006,Discussion,discussion
Kaarisalo_2006,all_tables,tables
Kaarisalo_2006,all_figure_descriptions,figures
Laukkanen_2013,Abstract,abstract
Laukkanen_2013,S,intro
Laukkanen_2013,RESEARCH DESIGN AND METHODS,methods
Laukkanen_2013,Study population,methods
Laukkanen_2013,Assessment of risk factors,methods
Laukkanen_2013,Classification of outcomes,methods
Laukkanen_2013,Statistical analysis,methods
Laukkanen_2013,RESULTS,results
Laukkanen_2013,Baseline characteristics,results
Laukkanen_2013,Numbers of outcome events during the follow-up,results
Laukkanen_2013,"FPG, insulin resistance, and type 2 diabetes risk factors for SCD",results
Laukkanen_2013,all_tables,tables
Laukkanen_2013,all_figure_descriptions,figures
Ares_2019,Abstract,abstract
Ares_2019,Introduction,intro
Ares_2019,Materials and methods,methods
Ares_2019,The asturias study,methods
Ares_2019,Measurements,methods
Ares_2019,Follow up and mortality,methods
Ares_2019,Statistical analysis,methods
Ares_2019,Results,results
Ares_2019,Baseline characteristics,results
Ares_2019,Mortality by glucose tolerance categories,results
Ares_2019,"Cause of death, age, and sex differences",results
Ares_2019,Discussion,discussion
Ares_2019,Conclusion,conclusions
Ares_2019,all_tables,tables
Ares_2019,all_figure_descriptions,figures
Rijkelijkhuizen_2007,Abstract,abstract
Rijkelijkhuizen_2007,I,intro
Rijkelijkhuizen_2007,RESEARCH DESIGN AND METHODS,methods
Rijkelijkhuizen_2007,Study population,methods
Rijkelijkhuizen_2007,Glucose intolerance classification,methods
Rijkelijkhuizen_2007,Measurements,methods
Rijkelijkhuizen_2007,Follow-up of mortality,methods
Rijkelijkhuizen_2007,Statistical analysis,methods
Rijkelijkhuizen_2007,RESULTS,results
Rijkelijkhuizen_2007,Limitations of the study,discussion
Rijkelijkhuizen_2007,Consequences of lowering the IFG cutoff for the prevalence of IFG and incidence rate of diabetes,discussion
Rijkelijkhuizen_2007,Fasting glucose and cardiovascular mortality,discussion
Rijkelijkhuizen_2007,Consequences of lowering the IFG cutoff for early prediction of CVD and diabetes,discussion
Rijkelijkhuizen_2007,all_tables,tables
Rijkelijkhuizen_2007,all_figure_descriptions,figures
McNeill_2006,Abstract,abstract
McNeill_2006,OBJECTIVES:,intro
McNeill_2006,METHODS,methods
McNeill_2006,Classification of MetS,methods
McNeill_2006,Ascertainment of Incident Events,methods
McNeill_2006,Statistical Analysis,methods
McNeill_2006,RESULTS,results
McNeill_2006,˙SCUSSI ˙ON,discussion
McNeill_2006,ACKNOWLEDGMENTS,misc.
McNeill_2006,all_tables,tables
McNeill_2006,all_figure_descriptions,figures
Zhang_2008,Abstract,abstract
Zhang_2008,Baseline Evaluation,methods
Zhang_2008,Outcome Variables,methods
Zhang_2008,Fatal Stroke,methods
Zhang_2008,Nonfatal Stroke,methods
Zhang_2008,Statistical Analysis,methods
Zhang_2008,Results,results
Zhang_2008,Prior Stroke,results
Zhang_2008,Incidence Rate of Stroke,results
Zhang_2008,Stroke Subtypes,results
Zhang_2008,Age of Occurrence of First Stroke,results
Zhang_2008,Characteristics of Participants With or Without Incident Stroke,results
Zhang_2008,Risk Factors for Stroke,results
Zhang_2008,Discussion,discussion
Zhang_2008,Zhang et al Stroke in American Indians,discussion
Zhang_2008,Incidence,discussion
Zhang_2008,Case Fatality of First Stroke,discussion
Zhang_2008,all_tables,tables
Zhang_2008,all_figure_descriptions,figures
Lu_2003,Abstract,abstract
Lu_2003,INTRODUCTION,intro
Lu_2003,RESEARCH DESIGN AND METHODS,methods
Lu_2003,RESULTS,results
Lu_2003,all_tables,tables
Lu_2003,all_figure_descriptions,figures
Mathenge_2020,Abstract,abstract
Mathenge_2020,Introduction,intro
Mathenge_2020,"Pre-diabetes, diabetes and predictors of incident angina among older women and men in the Cardiovascular Health Study",intro
Mathenge_2020,Methods,methods
Mathenge_2020,Results,results
Mathenge_2020,Discussion,discussion
Mathenge_2020,all_tables,tables
Mathenge_2020,all_figure_descriptions,figures
Kowall_2011,Abstract,abstract
Kowall_2011,Introduction,intro
Kowall_2011,Ö Springer,intro
Kowall_2011,Methods,methods
Kowall_2011,Study population,methods
Kowall_2011,Physical examinations and interviews,methods
Kowall_2011,Laboratory measurements,methods
Kowall_2011,Definition of covariables,methods
Kowall_2011,Statistical analyses,methods
Kowall_2011,Categories of glucose regulation and mortality,methods
Kowall_2011,Results,results
Kowall_2011,Study population characteristics,results
Kowall_2011,Mortality by glucose tolerance categories,results
Kowall_2011,Glycemic measures and mortality,results
Kowall_2011,Discussion,discussion
Kowall_2011,All-cause mortality in known and undiagnosed diabetes,discussion
Kowall_2011,Cancer and cardiovascular mortality in known and undiagnosed diabetes,discussion
Kowall_2011,Relationship between continuous glucose measures and mortality,discussion
Kowall_2011,Study limitations and strengths,discussion
Kowall_2011,Conclusion,conclusions
Kowall_2011,all_tables,tables
Kowall_2011,all_figure_descriptions,figures
Tai_2004,Abstract,abstract
Tai_2004,T,intro
Tai_2004,RESEARCH DESIGN AND,methods
Tai_2004,RESULTS -,results
Tai_2004,CONCLUSIONS -In the follow-up report on the diagnosis of the,discussion
Tai_2004,all_tables,tables
Tai_2004,all_figure_descriptions,figures
Yeboah_2011,Abstract,abstract
Yeboah_2011,Methods,methods
Yeboah_2011,Study population and data collection.,methods
Yeboah_2011,Results,results
Yeboah_2011,Discussion,discussion
Yeboah_2011,Conclusions,conclusions
Yeboah_2011,all_tables,tables
Yeboah_2011,all_figure_descriptions,figures
Wang_2019,Abstract,abstract
Wang_2019,Methods,methods
Wang_2019,Study Design and Population,methods
Wang_2019,Data Collection,methods
Wang_2019,Key Points,methods
Wang_2019,Assessment of Prediabetes and Diabetes,methods
Wang_2019,Ascertainment of Cardiovascular Events,methods
Wang_2019,Statistical Analysis,methods
Wang_2019,Results,results
Wang_2019,Discussion,discussion
Wang_2019,Strengths and Limitations,discussion
Wang_2019,Conclusions,conclusions
Wang_2019,ARTICLE INFORMATION,misc.
Wang_2019,Accepted for,misc.
Wang_2019,all_tables,tables
Wang_2019,all_figure_descriptions,figures
Nakagami_2004,Abstract,abstract
Nakagami_2004,T. Nakagami • the DECODA Study Group,intro
Nakagami_2004,Subjects and methods,methods
Nakagami_2004,Results,results
Nakagami_2004,Discussion,discussion
Nakagami_2004,all_tables,tables
Nakagami_2004,all_figure_descriptions,figures
Wandell_2005,Abstract,abstract
Wandell_2005,Materials and methods,methods
Wandell_2005,Blood glucose values,methods
Wandell_2005,Covariates,methods
Wandell_2005,Follow-up,methods
Wandell_2005,Statistical analysis,methods
Wandell_2005,Ethics,methods
Wandell_2005,Results,results
Wandell_2005,Table I,results
Wandell_2005,Men,results
Wandell_2005,Table II,results
Wandell_2005,All deaths CVD-deaths,results
Wandell_2005,Discussion,discussion
Wandell_2005,all_tables,tables
Wandell_2005,all_figure_descriptions,figures
Gordon-Dseagu_2015,Abstract,abstract
Gordon-Dseagu_2015,Introduction,intro
Gordon-Dseagu_2015,Materials and Methods,methods
Gordon-Dseagu_2015,Participants and data,methods
Gordon-Dseagu_2015,Statistical analysis,methods
Gordon-Dseagu_2015,Results,results
Gordon-Dseagu_2015,Characteristic of the study sample,results
Gordon-Dseagu_2015,All-cause mortality,results
Gordon-Dseagu_2015,Cancer and cardiovascular disease mortality,results
Gordon-Dseagu_2015,Discussion,discussion
Gordon-Dseagu_2015,Conclusion,conclusions
Gordon-Dseagu_2015,all_tables,tables
Gordon-Dseagu_2015,all_figure_descriptions,figures
McNeill_2005,Abstract,abstract
McNeill_2005,Criteria for the metabolic syndrome,methods
McNeill_2005,Ascertainment of cardiovascular outcomes,methods
McNeill_2005,Statistical analysis,methods
McNeill_2005,RESULTS,results
McNeill_2005,all_tables,tables
McNeill_2005,all_figure_descriptions,figures
Rhee_2020,Abstract,abstract
Rhee_2020,Introduction,intro
Rhee_2020,Methods,methods
Rhee_2020,NHIS Database and NHIS Health Checkup Data,methods
Rhee_2020,Measurements,methods
Rhee_2020,Study Design and Definition of Diseases,methods
Rhee_2020,Statistical Analysis,methods
Rhee_2020,Results,results
Rhee_2020,1.,results
Rhee_2020,Discussion,discussion
Rhee_2020,all_tables,tables
Rhee_2020,all_figure_descriptions,figures
Kokubo_2010,Abstract,abstract
Kokubo_2010,INTRODUCTION,intro
Kokubo_2010,METHODS,methods
Kokubo_2010,Study subjects,methods
Kokubo_2010,Measurement of BP and fasting glucose,methods
Kokubo_2010,Confirmation of stroke and coronary heart disease and end point determination,methods
Kokubo_2010,Statistical analysis,methods
Kokubo_2010,RESULTS,results
Kokubo_2010,DISCUSSION,discussion
Kokubo_2010,Men Women,discussion
Kokubo_2010,CONFLICT OF INTEREST,misc.
Kokubo_2010,all_tables,tables
Kokubo_2010,all_figure_descriptions,figures
Ma_2003,Abstract,abstract
Ma_2003,MATERIALS AND METHODS,methods
Ma_2003,Study population,methods
Ma_2003,"TABLE 1. Distributions of socioeconomic variables and other risk factors by ethnic group among Singaporeans aged 18-69 years, Singapore National Health Survey, 1992",methods
Ma_2003,Mortality follow-up,methods
Ma_2003,Statistical analysis,methods
Ma_2003,RESULTS,results
Ma_2003,DISCUSSION,discussion
Ma_2003,all_tables,tables
Ma_2003,all_figure_descriptions,figures
Selvin_2010,Abstract,abstract
Selvin_2010,Conclusions,intro
Selvin_2010,Me thods,methods
Selvin_2010,Study Population,methods
Selvin_2010,Measurement of Glycated Hemoglobin,methods
Selvin_2010,Assessment of Diabetes,methods
Selvin_2010,Other Variables of Interest,methods
Selvin_2010,"Surveillance for Newly Diagnosed Coronary Heart Disease, Stroke, and Death from Any Cause",methods
Selvin_2010,Statistical Analysis,methods
Selvin_2010,R esult s,results
Selvin_2010,Discussion,discussion
Selvin_2010,col 36p6,discussion
Selvin_2010,Adjusted,discussion
Selvin_2010,all_tables,tables
Selvin_2010,all_figure_descriptions,figures
Qiu_2015,Abstract,abstract
Qiu_2015,Measurement of Blood Glucose,methods
Qiu_2015,Measurement of Blood Pressure,methods
Qiu_2015,Assessment of Major Outcomes,methods
Qiu_2015,Other Variables of Interest,methods
Qiu_2015,Statistical Analyses,methods
Qiu_2015,Results,results
Qiu_2015,Discussion,discussion
Qiu_2015,Adjusted Odds Ratio for Diabetes Mellitus and Cardiovascular Disease According to the Blood Glucose at Baseline,discussion
Qiu_2015,Outcome,discussion
Qiu_2015,Perspectives,discussion
Qiu_2015,all_tables,tables
Qiu_2015,all_figure_descriptions,figures
Kim_2008,Abstract,abstract
Kim_2008,C,intro
Kim_2008,RESEARCH DESIGN AND METHODS,methods
Kim_2008,Statistical analysis,methods
Kim_2008,RESULTS,results
Kim_2008,all_tables,tables
Kim_2008,all_figure_descriptions,figures
Parizadeh_2019,Abstract,abstract
Parizadeh_2019,Introduction,intro
Parizadeh_2019,Methods,methods
Parizadeh_2019,Study design and setting,methods
Parizadeh_2019,Study population,methods
Parizadeh_2019,Clinical and laboratory measurements,methods
Parizadeh_2019,Definition of terms,methods
Parizadeh_2019,Statistical analysis,methods
Parizadeh_2019,Results,results
Parizadeh_2019,Limitations,discussion
Parizadeh_2019,Conclusions,conclusions
Parizadeh_2019,all_tables,tables
Parizadeh_2019,all_figure_descriptions,figures
Selvin_2013,Abstract,abstract
Selvin_2013,RESEARCH DESIGN AND METHODS,methods
Selvin_2013,Study population,methods
Selvin_2013,Measurement of glucose and HbA 1c,methods
Selvin_2013,Outcomes,methods
Selvin_2013,Covariates,methods
Selvin_2013,Statistical analyses,methods
Selvin_2013,all_tables,tables
Selvin_2013,all_figure_descriptions,figures
Tian_2018,Abstract,abstract
Tian_2018,RESEARCH DESIGN AND METHODS,methods
Tian_2018,Study Population,methods
Tian_2018,Study End Points,methods
Tian_2018,BP and Blood Glucose Measurement,methods
Tian_2018,Other Variables of Interest,methods
Tian_2018,Data Analysis,methods
Tian_2018,RESULTS,results
Tian_2018,Baseline Characteristics,results
Tian_2018,BP Categories and CVD,results
Tian_2018,CONCLUSIONS,discussion
Tian_2018,all_tables,tables
Tian_2018,all_figure_descriptions,figures
Evans_2015,Abstract,abstract
Evans_2015,Key messages,intro
Evans_2015,RESEARCH DESIGN AND METHODS,methods
Evans_2015,RESULTS,results
Evans_2015,CONCLUSIONS,discussion
Evans_2015,all_tables,tables
Evans_2015,all_figure_descriptions,figures
Deng_2017,Abstract,abstract
Deng_2017,Introduction,intro
Deng_2017,Methods,methods
Deng_2017,Results,results
Deng_2017,Discussion,discussion
Deng_2017,all_tables,tables
Deng_2017,all_figure_descriptions,figures
Hiltunen_2005,Abstract,abstract
Hiltunen_2005,Introduction,intro
Hiltunen_2005,Subjects and methods,methods
Hiltunen_2005,Statistical methods,methods
Hiltunen_2005,Results,results
Hiltunen_2005,Discussion,discussion
Hiltunen_2005,all_tables,tables
Hiltunen_2005,all_figure_descriptions,figures
Saito_2011,Abstract,abstract
Saito_2011,Introduction,intro
Saito_2011,Measurements,methods
Saito_2011,Confirmation of incident CHD,methods
Saito_2011,Statistical analyses,methods
Saito_2011,Results,results
Saito_2011,Discussion,discussion
Saito_2011,all_tables,tables
Saito_2011,all_figure_descriptions,figures
Mazza_2001,Abstract,abstract
Mazza_2001,Introduction,intro
Mazza_2001,Materials and methods,methods
Mazza_2001,General protocol,methods
Mazza_2001,Electrocardiogram (EKG) was analysed on the basis of the Minnesota Code,methods
Mazza_2001,Results,results
Mazza_2001,Univariate analysis,results
Mazza_2001,Multivariate prediction of stroke mortality,results
Mazza_2001,Role of blood electrolytes,results
Mazza_2001,Very old subjects,results
Mazza_2001,Discussion,discussion
Mazza_2001,Conclusions,conclusions
Mazza_2001,all_tables,tables
Mazza_2001,all_figure_descriptions,figures
Ma_2012,Abstract,abstract
Ma_2012,INTRODUCTION,intro
Ma_2012,METHODS,methods
Ma_2012,Study Population and Data Collection,methods
Ma_2012,Definition of Main Exposure and Outcome Variables,methods
Ma_2012,Statistical Analysis,methods
Ma_2012,RESULTS,results
Ma_2012,Interaction Between Diabetes and BMI for CVD Mortality,results
Ma_2012,DISCUSSION,discussion
Ma_2012,all_tables,tables
Ma_2012,all_figure_descriptions,figures
Khang_2010,Abstract,abstract
Khang_2010,Introduction,intro
Khang_2010,Methods,methods
Khang_2010,Study subjects,methods
Khang_2010,Outcome ascertainment,methods
Khang_2010,Definition of the metabolic syndrome,methods
Khang_2010,"Variables on bio-clinical factors, health behaviours, family medical history, and socio-demographic factors",methods
Khang_2010,Statistical analysis,methods
Khang_2010,Results,results
Khang_2010,Discussion,discussion
Khang_2010,all_tables,tables
Khang_2010,all_figure_descriptions,figures
Selvin_2014,Abstract,abstract
Selvin_2014,Methods,methods
Selvin_2014,Study Population,methods
Selvin_2014,Definitions of Diabetes Mellitus and Prediabetes,methods
Selvin_2014,Measurement of hs-cTnT,methods
Selvin_2014,Other Variables,methods
Selvin_2014,"Incident Coronary Heart Disease, Heart Failure, and All-Cause Mortality",methods
Selvin_2014,Statistical Analyses,methods
Selvin_2014,Results,results
Selvin_2014,Discussion,discussion
Selvin_2014,Circulation,discussion
Selvin_2014,all_tables,tables
Selvin_2014,all_figure_descriptions,figures
Tang_2020,Abstract,abstract
Tang_2020,RESEARCH DESIGN AND METHODS,methods
Tang_2020,Study Population,methods
Tang_2020,Assessment of Diabetes Status at Baseline and Definitions,methods
Tang_2020,Assessment of Cardiovascular Disease Status at Baseline and Definitions,methods
Tang_2020,Covariate Assessment and Definitions,methods
Tang_2020,Outcomes,methods
Tang_2020,RESULTS,results
Tang_2020,CONCLUSIONS,discussion
Tang_2020,all_tables,tables
Tang_2020,all_figure_descriptions,figures
Hajebrahimi_2017,Abstract,abstract
Hajebrahimi_2017,INTRODUCTION,intro
Hajebrahimi_2017,PATIENTS AND METHODS,methods
Hajebrahimi_2017,Study population,methods
Hajebrahimi_2017,Clinical and laboratory measurement,methods
Hajebrahimi_2017,Definition of terms,methods
Hajebrahimi_2017,Definition of outcomes,methods
Hajebrahimi_2017,Statistical analysis,methods
Hajebrahimi_2017,RESULTS,results
Hajebrahimi_2017,DISCUSSION,discussion
Hajebrahimi_2017,all_tables,tables
Hajebrahimi_2017,all_figure_descriptions,figures
Nakanishi_2004,Abstract,abstract
Nakanishi_2004,Introduction,intro
Nakanishi_2004,Research design and methods,methods
Nakanishi_2004,Study cohort,methods
Nakanishi_2004,Study design,methods
Nakanishi_2004,Statistical analysis,methods
Nakanishi_2004,Results,results
Nakanishi_2004,Discussion,discussion
Nakanishi_2004,all_tables,tables
Nakanishi_2004,all_figure_descriptions,figures
Oizumi_2008,Abstract,abstract
Oizumi_2008,Introduction,intro
Oizumi_2008,Subjects and methods,methods
Oizumi_2008,Subjects,methods
Oizumi_2008,Statistical methods,methods
Oizumi_2008,Results,results
Oizumi_2008,Clinical characteristics of the study groups,results
Oizumi_2008,IGT is a risk factor for stroke,results
Oizumi_2008,IFG is not a risk factor for stroke,results
Oizumi_2008,Discussion,discussion
Oizumi_2008,all_tables,tables
Oizumi_2008,all_figure_descriptions,figures
Hu_2003,Abstract,abstract
Hu_2003,Subjects and methods,methods
Hu_2003,Results,results
Hu_2003,Discussion,discussion
Hu_2003,all_tables,tables
Hu_2003,all_figure_descriptions,figures
Liu_2007,Abstract,abstract
Liu_2007,Methods,methods
Liu_2007,Subjects,methods
Liu_2007,Ascertainment of CHD and stroke,methods
Liu_2007,Statistical analysis,methods
Liu_2007,Results,results
Liu_2007,American Heart Journal April 2007,results
Liu_2007,Discussion,discussion
Liu_2007,all_tables,tables
Liu_2007,all_figure_descriptions,figures
Hyvarinen_2009,Abstract,abstract
Hyvarinen_2009,Participants and Methods,methods
Hyvarinen_2009,Study Population,methods
Hyvarinen_2009,Definition of the First Stroke Events,methods
Hyvarinen_2009,Statistical Methods,methods
Hyvarinen_2009,Results,results
Hyvarinen_2009,Discussion,discussion
Hyvarinen_2009,all_tables,tables
Hyvarinen_2009,all_figure_descriptions,figures
Onat_2005,Abstract,abstract
Onat_2005,Introduction,intro
Onat_2005,Methods,methods
Onat_2005,Population sample,methods
Onat_2005,"Definitions of IFG, glucose tolerance, DM, GM, and MS",methods
Onat_2005,Measurement of risk factors and validation,methods
Onat_2005,Ascertainment of cause of death and diagnosis of coronary heart disease,methods
Onat_2005,Data analysis,methods
Onat_2005,Results,results
Onat_2005,Features of the 4 groups with normal GM,results
Onat_2005,Incidence of newly developing abnormal GM,results
Onat_2005,Predictors of abnormal GM,results
Onat_2005,Predictors of CVD,results
Onat_2005,Discussion,discussion
Onat_2005,Sex difference in developing obesity or MS relative to the incidence of abnormal GM,discussion
Onat_2005,Hypothesis that men and women have divergent pathways supported,discussion
Onat_2005,Men Women,discussion
Onat_2005,all_tables,tables
Onat_2005,all_figure_descriptions,figures
Kim_2017,Abstract,abstract
Kim_2017,Methods,methods
Kim_2017,Study Population,methods
Kim_2017,Determinants of Glucose Tolerance State and Mortality,methods
Kim_2017,Statistical Analyses,methods
Kim_2017,Results,results
Kim_2017,Stroke,results
Kim_2017,Characteristics of the 2002 to 2013 NHIS Cohort Participants According to Their Glucose Tolerance State,results
Kim_2017,Discussion,discussion
Kim_2017,Summary,conclusions
Kim_2017,all_tables,tables
Kim_2017,all_figure_descriptions,figures
Onat_2013,Abstract,abstract
Onat_2013,Introduction,intro
Onat_2013,Population and methods,methods
Onat_2013,Subjects,methods
Onat_2013,Measurements of risk variables,methods
Onat_2013,Definitions and outcomes,methods
Onat_2013,Data analysis,methods
Onat_2013,Results,results
Onat_2013,Discussion,discussion
Onat_2013,HDL function associated with low-grade inflammation mediates development of IFG and IGT,discussion
Onat_2013,Impact of impaired glucose regulation on CHD,discussion
Onat_2013,Utility of different glucose criteria in risks for diabetes CHD,discussion
Onat_2013,Limitations,discussion
Onat_2013,Conclusions,conclusions
Onat_2013,all_tables,tables
Onat_2013,all_figure_descriptions,figures
Stengard_1992,Abstract,abstract
Stengard_1992,"Subjects, materials and methods",methods
Stengard_1992,Statistical analysis,methods
Stengard_1992,Results,results
Stengard_1992,Discussion,discussion
Stengard_1992,all_tables,tables
Stengard_1992,all_figure_descriptions,figures
Tsai_2008,Abstract,abstract
Tsai_2008,Introduction,intro
Tsai_2008,Research design and methods,methods
Tsai_2008,Results,results
Tsai_2008,Discussion,discussion
Tsai_2008,all_tables,tables
Tsai_2008,all_figure_descriptions,figures
DECODE_2001,Abstract,abstract
DECODE_2001,Conclusion:,intro
DECODE_2001,Arch Intern,intro
DECODE_2001,ORIGINAL INVESTIGATION,intro
DECODE_2001,RESULTS,results
DECODE_2001,PARTICIPANTS AND METHODS,methods
DECODE_2001,STATISTICAL ANALYSIS,methods
DECODE_2001,COMMENT,discussion
DECODE_2001,Accepted for publication,misc.
DECODE_2001,all_tables,tables
DECODE_2001,all_figure_descriptions,figures
Kim_2016,Abstract,abstract
Kim_2016,Introduction,intro
Kim_2016,Methods,methods
Kim_2016,Data sources,methods
Kim_2016,Disease definitions,methods
Kim_2016,Obesity and hypertension,methods
Kim_2016,Definitions of dysglycemia,methods
Kim_2016,Outcome definitions,methods
Kim_2016,Statistical analyses,methods
Kim_2016,Results,results
Kim_2016,Table 1 lists the baseline characteristics of participants.,results
Kim_2016,Discussion,discussion
Kim_2016,all_tables,tables
Kim_2016,all_figure_descriptions,figures
Bonora_2003,Abstract,abstract
Bonora_2003,A,intro
Bonora_2003,RESEARCH DESIGN AND METHODS,methods
Bonora_2003,Subjects,methods
Bonora_2003,Clinical data,methods
Bonora_2003,Laboratory data,methods
Bonora_2003,Diagnostic criteria of the metabolic syndrome,methods
Bonora_2003,Assessment and definition of insulin resistance,methods
Bonora_2003,Assessment of carotid atherosclerosis,methods
Bonora_2003,Assessment of CHD,methods
Bonora_2003,Statistical analysis,methods
Bonora_2003,RESULTS,results
Bonora_2003,all_tables,tables
Bonora_2003,all_figure_descriptions,figures
Wang_2007_2,Abstract,abstract
Wang_2007_2,Instruction,intro
Wang_2007_2,Methods,methods
Wang_2007_2,Study population,methods
Wang_2007_2,Measurements,methods
Wang_2007_2,Diagnosis of diabetes and CHD,methods
Wang_2007_2,Study groups,methods
Wang_2007_2,Definitions of the MetS,methods
Wang_2007_2,Statistical analyses,methods
Wang_2007_2,Results,results
Wang_2007_2,Discussion,discussion
Wang_2007_2,all_tables,tables
Wang_2007_2,all_figure_descriptions,figures
Rodriguez_2002,Abstract,abstract
Rodriguez_2002,P,intro
Rodriguez_2002,RESEARCH DESIGN AND METHODS,methods
Rodriguez_2002,Study design,methods
Rodriguez_2002,Data collection,methods
Rodriguez_2002,Statistical methods,methods
Rodriguez_2002,RESULTS -Table,results
Rodriguez_2002,all_tables,tables
Rodriguez_2002,all_figure_descriptions,figures
Chien_2008,Abstract,abstract
Chien_2008,Subjects and methods,methods
Chien_2008,Study participants,methods
Chien_2008,Measurement of glucose metabolism markers,methods
Chien_2008,Results,results
Chien_2008,Discussion,discussion
Chien_2008,all_tables,tables
Chien_2008,all_figure_descriptions,figures
Hubbard_2019,Abstract,abstract
Hubbard_2019,RESEARCH DESIGN AND METHODS,methods
Hubbard_2019,Study Population,methods
Hubbard_2019,Data Collection,methods
Hubbard_2019,Outcome Definitions,methods
Hubbard_2019,Statistical Analyses,methods
Hubbard_2019,RESULTS,results
Hubbard_2019,Participant Characteristics,results
Hubbard_2019,Risk for Incident CVD and All-Cause Mortality,results
Hubbard_2019,Secondary Analysis: Risk for Incident Diabetes,results
Hubbard_2019,CONCLUSIONS,discussion
Hubbard_2019,all_tables,tables
Hubbard_2019,all_figure_descriptions,figures
Kim_2013,Abstract,abstract
Kim_2013,RESEARCH DESIGN AND,methods
Kim_2013,Data collection,methods
Kim_2013,Outcome ascertainment,methods
Kim_2013,Disease definitions (definition of dysglycemia),methods
Kim_2013,Statistical analysis,methods
Kim_2013,all_tables,tables
Kim_2013,all_figure_descriptions,figures
Levitzky_2008,Abstract,abstract
Levitzky_2008,Methods,methods
Levitzky_2008,Study sample.,methods
Levitzky_2008,Impact of the IFG definition on incident CHD and,results
Levitzky_2008,Discussion,discussion
Levitzky_2008,Conclusions,conclusions
Levitzky_2008,all_tables,tables
Levitzky_2008,all_figure_descriptions,figures
Brunner_2010,Abstract,abstract
Brunner_2010,Introduction,intro
Brunner_2010,Subjects and methods,methods
Brunner_2010,Study sample,methods
Brunner_2010,Follow-up for coronary heart disease,methods
Brunner_2010,Fasting glucose and diabetes at baseline,methods
Brunner_2010,Analysis,methods
Brunner_2010,Results,results
Brunner_2010,DIABETICMedicine,results
Brunner_2010,Original article,results
Brunner_2010,Discussion,discussion
Brunner_2010,Competing interests,misc.
Brunner_2010,all_tables,tables
Brunner_2010,all_figure_descriptions,figures
Cederberg_2010,Abstract,abstract
Cederberg_2010,RESEARCH DESIGN AND,methods
Cederberg_2010,Procedures,methods
Cederberg_2010,Cardiovascular and mortality outcomes,methods
Cederberg_2010,Statistical analysis,methods
Cederberg_2010,RESULTS,results
Cederberg_2010,all_tables,tables
Cederberg_2010,all_figure_descriptions,figures
Barzilay_1999,Abstract,abstract
Barzilay_1999,M e t h o d s,abstract
Barzilay_1999,I n t r o d u c t i o n,intro
Barzilay_1999,Patients and methods,methods
Barzilay_1999,Study design,methods
Barzilay_1999,Statistical analysis,methods
Barzilay_1999,D i s c u s s i o n,discussion
Barzilay_1999,A c k n o w l e d g m e n t s,misc.
Barzilay_1999,all_tables,tables
Barzilay_1999,all_figure_descriptions,figures
Palmieri_2006,Abstract,abstract
Palmieri_2006,Introduction,intro
Palmieri_2006,Methods,methods
Palmieri_2006,Population samples,methods
Palmieri_2006,Baseline measurements,methods
Palmieri_2006,Coronary events registration/validation,methods
Palmieri_2006,Data analyses,methods
Palmieri_2006,Results,results
Palmieri_2006,Baseline descriptive statistics,results
Palmieri_2006,Coronary heart disease incidence,results
Palmieri_2006,Relation of baseline risk status to coronary heart disease,results
Palmieri_2006,Relation of risk factors considered singly to coronary heart disease risk,results
Palmieri_2006,Relation of multiple risk factors considered together to coronary heart disease risk,results
Palmieri_2006,Discussion,discussion
Palmieri_2006,all_tables,tables
Palmieri_2006,all_figure_descriptions,figures
Lu_2019,Abstract,abstract
Lu_2019,RESEARCH DESIGN AND METHODS,methods
Lu_2019,Study Participants,methods
Lu_2019,Baseline Data Collection,methods
Lu_2019,14,methods
Lu_2019,Follow-up and Outcome Assessment,methods
Lu_2019,Statistical Analyses,methods
Lu_2019,RESULTS,results
Lu_2019,Glycemic Measures and Incident Diabetes,results
Lu_2019,Predictive Values of Glycemic Measures,results
Lu_2019,CONCLUSIONS,conclusions
Lu_2019,all_tables,tables
Lu_2019,all_figure_descriptions,figures
Skriver_2010,Abstract,abstract
Skriver_2010,Introduction,intro
Skriver_2010,Methods,methods
Skriver_2010,Study design,methods
Skriver_2010,Results,results
Skriver_2010,Discussion,discussion
Skriver_2010,all_tables,tables
Skriver_2010,all_figure_descriptions,figures
Hunt_2004,Abstract,abstract
Hunt_2004,"Study Population, Follow-Up, and Events",methods
Hunt_2004,Statistical Analyses,methods
Hunt_2004,Results,results
Hunt_2004,Discussion,discussion
Hunt_2004,Hunt et al Metabolic Syndrome and Mortality,discussion
Hunt_2004,Age-and Gender-Adjusted Characteristics (Means or Proportions and 95% CIs) of the Study Population by NCEP and WHO Metabolic Syndrome,discussion
Hunt_2004,all_tables,tables
Hunt_2004,all_figure_descriptions,figures
Vistisen_2018,Abstract,abstract
Vistisen_2018,RESEARCH DESIGN AND METHODS,methods
Vistisen_2018,Study Design and Participants,methods
Vistisen_2018,Ethics,methods
Vistisen_2018,Definition of Prediabetes,methods
Vistisen_2018,Assessment of Clinical Characteristics,methods
Vistisen_2018,Outcome Ascertainment,methods
Vistisen_2018,Statistical Analysis,methods
Vistisen_2018,RESULTS,results
Vistisen_2018,Prediabetes by Different Definitions,results
Vistisen_2018,Event Rates in Individuals With Prediabetes by Different Definitions,results
Vistisen_2018,Overall Event Rates,results
Vistisen_2018,Event Rates by Glycemic Criteria,results
Vistisen_2018,Comparing Event Rates Between Nonoverlapping Groups,results
Vistisen_2018,Exploring Event Rates by Increasing of Glycemia,results
Vistisen_2018,CONCLUSIONS,discussion
Vistisen_2018,all_tables,tables
Vistisen_2018,all_figure_descriptions,figures
Henry_2002,Abstract,abstract
Henry_2002,Methods,methods
Henry_2002,Subjects,methods
Henry_2002,Data Analysis,methods
Henry_2002,Results,results
Henry_2002,Discussion,discussion
Henry_2002,Perspectives,conclusions
Henry_2002,all_tables,tables
Henry_2002,all_figure_descriptions,figures
Warren_2017,Abstract,abstract
Warren_2017,Introduction,intro
Warren_2017,Methods,methods
Warren_2017,Study design and participants,methods
Warren_2017,Research in context,intro
Warren_2017,Added value of this study,intro
Warren_2017,Implications of all the available evidence,intro
Warren_2017,Procedures,methods
Warren_2017,Statistical analysis,methods
Warren_2017,Role of the funding source,methods
Warren_2017,Results,results
Warren_2017,Discussion,discussion
Warren_2017,All-cause mortality,discussion
Warren_2017,"4: 10 year sensitivity, specifi city, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of incident clinical outcomes according to diff erent defi nitions of prediabetes versus normoglycaemia at baseline",discussion
Warren_2017,Contributors,misc.
Warren_2017,Declaration of interests,misc.
Warren_2017,all_tables,tables
Warren_2017,all_figure_descriptions,figures
Fang_2019,Abstract,abstract
Fang_2019,Introduction,intro
Fang_2019,Methods,methods
Fang_2019,Study design,methods
Fang_2019,Inclusion and exclusion criteria,methods
Fang_2019,Study procedures,methods
Fang_2019,Outcomes,methods
Fang_2019,Statistics analysis,methods
Fang_2019,Results,results
Fang_2019,Baseline characteristics,results
Fang_2019,Insulin resistance and ˇ cell function,results
Fang_2019,Incident T2DM,results
Fang_2019,Glycemic control,results
Fang_2019,Cardiovascular outcomes and cancer,results
Fang_2019,All-cause mortality,results
Fang_2019,Risk factors of all-cause mortality,results
Fang_2019,Discussion,discussion
Fang_2019,Conclusions,conclusions
Fang_2019,all_tables,tables
Fang_2019,all_figure_descriptions,figures
Shi_2016,Abstract,abstract
Shi_2016,Introduction,intro
Shi_2016,Methods,methods
Shi_2016,Study population,methods
Shi_2016,Data collection and measurements,methods
Shi_2016,Categories of glucose metabolism,methods
Shi_2016,Dietary measurements,methods
Shi_2016,Covariates,methods
Shi_2016,Death ascertainment,methods
Shi_2016,Statistical analysis,methods
Shi_2016,Results,results
Shi_2016,Interactions,results
Shi_2016,all_tables,tables
Shi_2016,all_figure_descriptions,figures
Sung_2009,Abstract,abstract
Sung_2009,Editorial p 773 Clinical Perspective p 819,intro
Sung_2009,Methods,methods
Sung_2009,Study Participants,methods
Sung_2009,Follow-Up of Cardiovascular Mortality and Morbidity,methods
Sung_2009,Analytical Methods,methods
Sung_2009,Results,results
Sung_2009,Discussion,discussion
Sung_2009,Figure.,discussion
Sung_2009,Sung et al,discussion
Sung_2009,all_tables,tables
Sung_2009,all_figure_descriptions,figures
Wild_2005,Abstract,abstract
Wild_2005,Subjects and methods,methods
Wild_2005,Results,results
Wild_2005,Discussion,discussion
Wild_2005,all_tables,tables
Wild_2005,all_figure_descriptions,figures
Welsh_2020,Abstract,abstract
Welsh_2020,RESEARCH DESIGN AND METHODS,methods
Welsh_2020,Statistical Analyses,methods
Welsh_2020,RESULTS,results
Welsh_2020,Cross Sectional Associations,results
Welsh_2020,CVD Outcomes,results
Welsh_2020,Association of HbA 1c with CVD Outcomes,results
Welsh_2020,HbA 1c and Prediction of CVD Outcomes in Addition to Classical Risk Factors,results
Welsh_2020,CONCLUSIONS,discussion
Welsh_2020,all_tables,tables
Welsh_2020,all_figure_descriptions,figures
Wang_2007,Abstract,abstract
Wang_2007,Introduction,intro
Wang_2007,Methods,methods
Wang_2007,Baseline study,methods
Wang_2007,Follow-up study,methods
Wang_2007,Definitions of the MetS,methods
Wang_2007,Statistical analyses,methods
Wang_2007,Results,results
Wang_2007,Discussion,discussion
Wang_2007,all_tables,tables
Wang_2007,all_figure_descriptions,figures
Mirbolouk_2016,Abstract,abstract
Mirbolouk_2016,Introduction,intro
Mirbolouk_2016,Materials and methods,methods
Mirbolouk_2016,Study population,methods
Mirbolouk_2016,Clinical and laboratory measurement,methods
Mirbolouk_2016,Definition of variables and CVD outcomes,methods
Mirbolouk_2016,Statistical analysis,methods
Mirbolouk_2016,Results,results
Mirbolouk_2016,Discussion,discussion
Mirbolouk_2016,|,discussion
Mirbolouk_2016,all_tables,tables
Mirbolouk_2016,all_figure_descriptions,figures
Rhee_2016,Abstract,abstract
Rhee_2016,1.,intro
Rhee_2016,Introduction,intro
Rhee_2016,Methods,methods
Rhee_2016,Study Population,methods
Rhee_2016,Data Collection,methods
Rhee_2016,Laboratory Analyses,methods
Rhee_2016,Mortality Follow-up,methods
Rhee_2016,Statistical Analysis,methods
Rhee_2016,Results,results
Rhee_2016,Discussion,discussion
Rhee_2016,Categories of HbA1c,discussion
Rhee_2016,Conclusions,conclusions
Rhee_2016,all_tables,tables
Rhee_2016,all_figure_descriptions,figures
Lazo-Porras_2020,Abstract,abstract
Lazo-Porras_2020,Introduction,intro
Lazo-Porras_2020,Methods,methods
Lazo-Porras_2020,"Study design, setting and participants",methods
Lazo-Porras_2020,Follow-up assessment,methods
Lazo-Porras_2020,Variables definition,methods
Lazo-Porras_2020,Laboratory procedures,methods
Lazo-Porras_2020,Statistical analysis,methods
Lazo-Porras_2020,Ethics,methods
Lazo-Porras_2020,Results,results
Lazo-Porras_2020,"Characteristics of the study population, stratified by death during follow-up",results
Lazo-Porras_2020,Discussion,discussion
Lazo-Porras_2020,Ethical Approval,misc.
Lazo-Porras_2020,all_tables,tables
Lazo-Porras_2020,all_figure_descriptions,figures
Ahn_2018,Abstract,abstract
Ahn_2018,Introduction,intro
Ahn_2018,Data collection,methods
Ahn_2018,Main outcome measures,methods
Ahn_2018,Statistical analysis,methods
Ahn_2018,Results,results
Ahn_2018,Discussion,discussion
Ahn_2018,3,discussion
Ahn_2018,Men Women,discussion
Ahn_2018,all_tables,tables
Ahn_2018,all_figure_descriptions,figures
Eastwood_2015,Abstract,abstract
Eastwood_2015,RESEARCH DESIGN AND METHODS,methods
Eastwood_2015,Study Participants and Design,methods
Eastwood_2015,Baseline Measurements,methods
Eastwood_2015,Follow-up Measurements,methods
Eastwood_2015,Statistical Analysis,methods
Eastwood_2015,RESULTS,results
Eastwood_2015,CONCLUSIONS,discussion
Eastwood_2015,all_tables,tables
Eastwood_2015,all_figure_descriptions,figures
Valdes_2009,Abstract,abstract
Valdes_2009,Follow-up and identification of Fatal Events,methods
Valdes_2009,METHoDS,methods
Valdes_2009,Asturias Study,methods
Valdes_2009,RESUlTS,results
Valdes_2009,Statistical Study,methods
Valdes_2009,3-fold greater than persons with normoglycemia the analysis adjusted for age and sex; these levels remained just slightly lower after the multivariate,discussion
Valdes_2009,ConClUSionS,conclusions
Valdes_2009,all_tables,tables
Valdes_2009,all_figure_descriptions,figures
Saydah_2001,Abstract,abstract
Saydah_2001,P,intro
Saydah_2001,RESEARCH DESIGN AND METHODS,methods
Saydah_2001,Data sources,methods
Saydah_2001,Participants,methods
Saydah_2001,Baseline assessments,methods
Saydah_2001,Outcomes,methods
Saydah_2001,Analysis,methods
Saydah_2001,RESULTS,results
Saydah_2001,Characteristics and risk factors at baseline,results
Saydah_2001,Mortality,results
Saydah_2001,Multivariate proportional hazards,results
Saydah_2001,CONCLUSIONS -,discussion
Saydah_2001,all_tables,tables
Saydah_2001,all_figure_descriptions,figures
de_Abreu_2017,Abstract,abstract
de_Abreu_2017,Introduction,intro
de_Abreu_2017,Methods,methods
de_Abreu_2017,Study Design and,methods
de_Abreu_2017,Statistical,methods
de_Abreu_2017,Results,results
de_Abreu_2017,Discussion,discussion
de_Abreu_2017,Conclusions,conclusions
de_Abreu_2017,all_tables,tables
de_Abreu_2017,all_figure_descriptions,figures
Schottker_2013,Abstract,abstract
Schottker_2013,Introduction,intro
Schottker_2013,Methods,methods
Schottker_2013,Statistical analyses,methods
Schottker_2013,Results,results
Schottker_2013,Distribution of cardiovascular risk factors in individuals with prediabetes and diabetes,results
Schottker_2013,Prediction of incident cardiovascular events in individuals diabetes,results
Schottker_2013,Discussion,discussion
Schottker_2013,Cardiovascular risk profiles,discussion
Schottker_2013,Conclusion,conclusions
Schottker_2013,all_tables,tables
Schottker_2013,all_figure_descriptions,figures
Pankow_2007,Abstract,abstract
Pankow_2007,RESEARCH DESIGN AND METHODS -The Atherosclerosis,methods
Pankow_2007,CVD risk factors and glucose,methods
Pankow_2007,Subclinical CVD,methods
Pankow_2007,Statistical analysis,methods
Pankow_2007,Glucose impairment and cardiometabolic risk,results
Pankow_2007,CONCLUSIONS -W e o b s e r v e d poor agreement between IFG and IGT using current ADA definitions for glucose impairment in nondiabetic individuals.,discussion
Pankow_2007,all_tables,tables
Pankow_2007,all_figure_descriptions,figures
Samaras_2015,Abstract,abstract
Samaras_2015,RESEARCH DESIGN AND METHODS,methods
Samaras_2015,Glucose Status Classification,methods
Samaras_2015,Procedures and Laboratory Analyses,methods
Samaras_2015,Statistical Analyses,methods
Samaras_2015,Cross-Sectional Statistical Analyses,methods
Samaras_2015,Prospective Statistical Analyses,methods
Samaras_2015,RESULTS,results
Samaras_2015,Baseline Disease Prevalence and Metabolic and Inflammatory Associations in IFG,results
Samaras_2015,Two-Year All-Cause Mortality and IFG,results
Samaras_2015,Two-Year Incident Cardiovascular Disease and Stroke and IFG,results
Samaras_2015,Two-Year Incident Cancer and IFG,results
Samaras_2015,"Diabetes Mellitus, Mortality, and Incident Disease",results
Samaras_2015,DISCUSSION,discussion
Samaras_2015,all_tables,tables
Samaras_2015,all_figure_descriptions,figures
Magliano_2010,Abstract,abstract
Magliano_2010,S,intro
Magliano_2010,Risk factors at baseline,methods
Magliano_2010,Causes of death,methods
Magliano_2010,Statistical analyses,methods
Magliano_2010,RESULTS,results
Magliano_2010,"-Adjusted all-cause (A) and CVD (B) mortality HRs (95% CIs) for IFG, IGT, NDM, and KDM compared with NGT according to ethnic",results
Magliano_2010,all_tables,tables
Magliano_2010,all_figure_descriptions,figures
Wang_2008,Abstract,abstract
Wang_2008,Subjects and Methods,methods
Wang_2008,Baseline Study,methods
Wang_2008,Diagnosis of Incident Stroke,methods
Wang_2008,Definitions of the MetS,methods
Wang_2008,Statistical Analyses,methods
Wang_2008,Results,results
Wang_2008,Discussion,discussion
Wang_2008,Wang et al Metabolic Syndrome and Stroke,discussion
Wang_2008,Sources of Funding,misc.
Wang_2008,all_tables,tables
Wang_2008,all_figure_descriptions,figures
Madssen_2012,Abstract,abstract
Madssen_2012,Introduction,intro
Madssen_2012,Material and methods,methods
Madssen_2012,The HUNT study,methods
Madssen_2012,Study variables,methods
Madssen_2012,Study population,methods
Madssen_2012,Follow-up,methods
Madssen_2012,Statistical analysis,methods
Madssen_2012,Results,results
Madssen_2012,Discussion,discussion
Madssen_2012,Potentially confounding factors,discussion
Madssen_2012,Abnormal glucose regulation and fatal CAD,discussion
Madssen_2012,Gender differences,discussion
Madssen_2012,Limitations of the study,discussion
Madssen_2012,Conclusions,conclusions
Madssen_2012,all_tables,tables
Madssen_2012,all_figure_descriptions,figures
Chattopadhyayv 2019,Abstract,abstract
Chattopadhyayv 2019,Introduction,intro
Chattopadhyayv 2019,Methods,methods
Chattopadhyayv 2019,Statistical analysis,methods
Chattopadhyayv 2019,Results,results
Chattopadhyayv 2019,Discussion,discussion
Chattopadhyayv 2019,all_tables,tables
Chattopadhyayv 2019,all_figure_descriptions,figures
Nigam_2007,Abstract,abstract
Nigam_2007,METHODS,methods
Nigam_2007,Study population,methods
Nigam_2007,Clinical variables,methods
Nigam_2007,"Definitions of IFG, PPH and diabetes",methods
Nigam_2007,Statistical analysis,methods
Nigam_2007,RESULTS,results
Nigam_2007,Baseline characteristics,results
Nigam_2007,DISCUSSION,discussion
Nigam_2007,CONCLUSIONS,conclusions
Nigam_2007,ACKNOWLEDGEMENTS:,misc.
Nigam_2007,all_tables,tables
Nigam_2007,all_figure_descriptions,figures
Tamita_2012,Abstract,abstract
Tamita_2012,METHODS,methods
Tamita_2012,Study patients,methods
Tamita_2012,Protocols,methods
Tamita_2012,Study endpoints and definitions,methods
Tamita_2012,Statistical analysis,methods
Tamita_2012,RESULTS,results
Tamita_2012,DISCUSSION,discussion
Tamita_2012,Prevalence of glucose intolerance in patients with AMI,discussion
Tamita_2012,Prognosis of patients with AMI with abnormal glucometabolic status,discussion
Tamita_2012,Hyperglycaemia after AMI: risk marker or therapeutic target,discussion
Tamita_2012,Study limitations,discussion
Tamita_2012,Conclusions,conclusions
Tamita_2012,all_tables,tables
Tamita_2012,all_figure_descriptions,figures
Intzilakis_2012,Abstract,abstract
Intzilakis_2012,Introduction,intro
Intzilakis_2012,Subjects and methods,methods
Intzilakis_2012,Endpoints,methods
Intzilakis_2012,Statistical analyses,methods
Intzilakis_2012,Results,results
Intzilakis_2012,Follow-up and events,results
Intzilakis_2012,DIABETICMedicine,results
Intzilakis_2012,Discussion,discussion
Intzilakis_2012,Competing interests,misc.
Intzilakis_2012,all_tables,tables
Intzilakis_2012,all_figure_descriptions,figures
Kanaya_2005,Abstract,abstract
Kanaya_2005,I,intro
Kanaya_2005,RESEARCH DESIGN AND METHODS,methods
Kanaya_2005,The RBS,methods
Kanaya_2005,Statistical analysis,methods
Kanaya_2005,RESULTS,results
Kanaya_2005,Four simple variables can predict diabetes,discussion
Kanaya_2005,all_tables,tables
Kanaya_2005,all_figure_descriptions,figures
Mainous_2014,Abstract,abstract
Mainous_2014,INTRODUCTION,intro
Mainous_2014,METHODS,methods
Mainous_2014,We conducted longitudinal analyses of the third National Health and Nutrition Examination,methods
Mainous_2014,Previously diagnosed diabetes,methods
Mainous_2014,Normoglycaemia and prediabetes,methods
Mainous_2014,Transferrin saturation,methods
Mainous_2014,Serum ferritin,methods
Mainous_2014,Mortality,methods
Mainous_2014,Covariates,methods
Mainous_2014,Analysis,methods
Mainous_2014,RESULTS,results
Mainous_2014,DISCUSSION,discussion
Mainous_2014,all_tables,tables
Mainous_2014,all_figure_descriptions,figures
Bergman_2015,Abstract,abstract
Bergman_2015,Introduction,intro
Bergman_2015,Materials and methods,methods
Bergman_2015,Study population,methods
Bergman_2015,Laboratory tests,methods
Bergman_2015,Definitions,methods
Bergman_2015,Statistical analysis,methods
Bergman_2015,Results,results
Bergman_2015,Discussion,discussion
Bergman_2015,all_tables,tables
Bergman_2015,all_figure_descriptions,figures